Summit Therapeutics SMMT
Last Price
52 Week Range
$15.55 - $36.91
Next Earnings Date
Feb 23 2026 (Estimate)
Next Earnings Date
Feb 23 2026 (Est.)
Last Price
SMMT Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Summit Therapeutics Inc. | 8-K | November 7, 2025 | |
Summit Therapeutics Inc. | S3ASR | October 29, 2025 | |
Summit Therapeutics Inc. | 8-K | October 22, 2025 | |
Summit Therapeutics Inc. | 8-K | October 20, 2025 | |
Summit Therapeutics Inc. | 8-K | September 8, 2025 | |
Summit Therapeutics Inc. | 8-K | August 11, 2025 | |
Summit Therapeutics Inc. | 8-K | August 11, 2025 | |
Summit Therapeutics Inc. | 10-Q | August 11, 2025 | |
Summit Therapeutics Inc. | 8-K | June 20, 2025 | |
Summit Therapeutics Inc. | 8-K | June 17, 2025 | |
Summit Therapeutics Inc. | 8-K | May 30, 2025 | |
Summit Therapeutics Inc. | 10-Q | May 1, 2025 | |
Summit Therapeutics Inc. | 8-K | May 1, 2025 | |
Summit Therapeutics Inc. | DEF 14A | April 29, 2025 | |
Summit Therapeutics Inc. | ARS | April 29, 2025 | |
Summit Therapeutics Inc. | 8-K | April 25, 2025 | |
Summit Therapeutics Inc. | 8-K | April 23, 2025 | |
Summit Therapeutics Inc. | 10-K | February 24, 2025 | |
Summit Therapeutics Inc. | 8-K | February 24, 2025 | |
Summit Therapeutics Inc. | 8-K | January 24, 2025 | |
Summit Therapeutics Inc. | 8-K | January 13, 2025 | |
Summit Therapeutics Inc. | 10-Q | October 30, 2024 | |
Summit Therapeutics Inc. | 8-K | October 30, 2024 | |
Summit Therapeutics Inc. | S3ASR | September 19, 2024 | |
Summit Therapeutics Inc. | 8-K | September 12, 2024 | |
Summit Therapeutics Inc. | 8-K | September 9, 2024 | |
Summit Therapeutics Inc. | 8-K | August 6, 2024 | |
Summit Therapeutics Inc. | 10-Q | August 6, 2024 | |
Summit Therapeutics Inc. | S3ASR | August 6, 2024 | |
Summit Therapeutics Inc. | 8-K | June 27, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.